CURRENT ISSUE Current Issue Cover
VOL 8 • NO 4 MAY/JUNE 2017
IN THIS ISSUE

The System Is All Holes and No Cheese

Krista Ramirez, PharmD, BCPS, and Christopher Campen, PharmD, BCOP


The Relationship Between Zinc and Quality of Life in Patients With Upper GI Cancer on Chemotherapy

Edith A. Brutcher,(1) RN, APRN-BC, AOCNP®, Zhengjia Chen,(2) PhD, Anqi Pan,(2) MSPH Candidate, and Tiffany Barrett,(1) MS, RD, CSO, LD


 
Section Seperator

TODAY'S NEWS

Digital Technology Preferences of Adoles...

There is considerable scope to develop digital res...

WCHN Launches Trial to Screen Newly Diag...

Western Connecticut Health Network (WCHN) has anno...

Effect of Postdiagnosis Aspirin and Othe...

As reported by Hua et al in the Journal of Clinica...

Accelerated vs Standard Epirubicin and C...

The phase III UK TACT2 trial has shown no efficacy...

ICML 2017: 3-Year Follow-up Showed Fourf...

Three-year follow-up data from the phase III RAY s...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

A Case-Based Approach for Multiple Myeloma

The clinical and scientific advances relative to multiple myeloma (MM) in the past decade have been staggering...

Palliative Chemo: Does It Only Provide False Hope?

A 48-year-old female with recent diagnosis of adenocarcinoma of unknown origin and metastatic disease to the peritoneum...

Bevacizumab in Serous Ovarian, Peritoneal Cancers

Despite the designation as an uncommon disease, rare cancers exert a significant burden...

Atypical Femoral Fractures: Implications for the AP

Advanced practitioners in oncology (APs) frequently encounter bone-health issues in oncology...

Ixazomib: An Oral Proteasome Inhibitor for MM

Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of plasma cells that produce monoclonal immunoglobulins, or paraproteins...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

ICML 2017: Data From the TRANSCEND Trial...

Data from the TRANSCEND trial of JCAR017 in relaps...

ICML 2017: Phase IIIb MAGNIFY Study of L...

An interim analysis of MAGNIFY, a phase IIIb, rand...

ICML 2017: Brentuximab Vedotin in Combin...

An updated interim analysis from an ongoing phase ...

ICML 2017: ADCT-402 Demonstrates Encoura...

Clinical data from an ongoing phase I clinical tri...

Equivalence Trial of Neoadjuvant Trastuz...

A phase III equivalence trial has shown comparable...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me